Insider Transactions in Q1 2023 at Generation Bio Co. (GBIO)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 26
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,695
-100.0%
|
$13,475
$5.56 P/Share
|
|
Jan 15
2023
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,578
-11.11%
|
$12,890
$5.1 P/Share
|
|
Jan 15
2023
|
Tracy Zimmermann CHIEF DEVELOPMENT OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,438
+24.28%
|
-
|
|
Jan 15
2023
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,430
-1.43%
|
$7,150
$5.1 P/Share
|
|
Jan 15
2023
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,125
+3.96%
|
-
|
|
Jan 15
2023
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,578
-1.16%
|
$12,890
$5.1 P/Share
|
|
Jan 15
2023
|
Matthew Stanton CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,438
+3.25%
|
-
|
|
Jan 15
2023
|
Geoff Mcdonough PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,122
-0.65%
|
$40,610
$5.1 P/Share
|
|
Jan 15
2023
|
Geoff Mcdonough PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
23,438
+1.84%
|
-
|
|
Jan 15
2023
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,578
-11.11%
|
$12,890
$5.1 P/Share
|
|
Jan 15
2023
|
Matthew Norkunas CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,438
+24.28%
|
-
|
|
Jan 15
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,430
-34.67%
|
$7,150
$5.1 P/Share
|
|
Jan 15
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
4,125
+50.0%
|
-
|
|
Jan 15
2023
|
Douglas Kerr CHIEF MEDICAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,578
-0.73%
|
$12,890
$5.1 P/Share
|
|
Jan 15
2023
|
Douglas Kerr CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,438
+2.06%
|
-
|
|
Jan 10
2023
|
Antoinette Paone CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
1,865
-100.0%
|
$7,460
$4.57 P/Share
|
|
Jan 09
2023
|
Phillip Samayoa CHIEF STRATEGY OFFICER |
SELL
Open market or private sale
|
Direct |
1,865
-1.91%
|
$9,325
$5.11 P/Share
|
|
Jan 05
2023
|
Ronald Harold Wilfred Cooper |
BUY
Grant, award, or other acquisition
|
Direct |
9,500
+50.0%
|
$47,500
$5.12 P/Share
|